A Phase III Clinical Study of Minodronate Tablets in Postmenopausal Women With Osteoporosis
Clinical trial NCT05305183 · UNKNOWN
Trial details
- NCT number
- NCT05305183
- Sponsor
- Shandong New Time Pharmaceutical Co., LTD
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-31
- Primary completion
- 2023-05-31
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.